Walleye Trading’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Walleye Trading’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-22,000	Closed	-$395	–	5034
2017 Q4	$395	Sell	22,000 -1,800	-8%	-$22.2K	﹤0.01%	2833
2017 Q3	$281	Buy	+23,800	New	+$267K	﹤0.01%	2963
2017 Q1	–	Sell	-36,400	Closed	-$493K	–	5415
2016 Q4	$493K	Buy	+36,400	New	+$508K	﹤0.01%	2093
2016 Q3	–	Sell	-1,700	Closed	-$19K	–	5812
2016 Q2	$19K	Buy	1,700 +1,672	+5,971%	+$18.7K	﹤0.01%	4601
2016 Q1	$0	Buy	+28	New	+$354	﹤0.01%	6138
2015 Q4	–	Sell	-1,423	Closed	-$28K	–	6012
2015 Q3	$28K	Buy	+1,423	New	+$32.6K	﹤0.01%	3892

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Walleye Trading's SCMP Position: Q1 2018 in Review

Walleye Trading sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 22,000 shares — an estimated $395 sold.

Walleye Trading first reported a position in SCMP in Q3 2015 and held it in 6 quarters. The position peaked at $493K in Q4 2016. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Walleye Trading reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Walleye Trading sold 22,000 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $395.
Walleye Trading first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 6 quarters.
Walleye Trading's Sucampo Pharmaceuticals, Inc. position peaked at $493K in Q4 2016.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Walleye Trading's 13F filing for Q1 2018, filed 15 May 2018.